Why US market has skyrocketed after Pfizer vaccine breakthrough : News Reel: Business Today
Business Today
Loading...
 

Why US market has skyrocketed after Pfizer vaccine breakthrough

Rajeev Dubey | November 10, 2020

In a major breakthrough in COVID-19 vaccine work, American pharmaceutical giant Pfizer and German firm BioNTech claimed that their vaccine candidate has been found to be 90% effective. The vaccine firms are the first drugmakers to show successful data from a large-scale clinical trial of coronavirus vaccine. The shots made by Pfizer and its German partner BioNTech are among 10 possible vaccine candidates in late-stage testing around the world. How Pfizer vaccine will act as a game changer for the US market, Rajeev Dubey, Editor, Business Today explains.

Also Read: Sensex crosses 43,000 for first time, Nifty nears 12,600 on COVID-19 vaccine hopes



    More from this section